Animalcare Group PLC (LSE:ANCR) - Share price


Stock Report

Animalcare Group PLC ANCR

Last Price
GBX341.00

Day Change
1.00|0.29%

As of 03/12/2021
17:08:24 GMT | GBX
Minimum 15 Minutes Delay.

Last Close340.00p
Day Range337.00 - 350.00
Mkt Cap204.90Mil
52-Wk Range180.00 - 430.00
Yield %1.17
ISINGB0032350695
Volume17,388
P/E3,333.33
P/S0.03
P/CF0.18

Share Price

Total Returns 03/12/2021

 Chg (%)  
More ...
Animalcare Group PLC-2.01 
FTSE 100 TR GBP-1.66
 
Financials
201820192020
More ...
Income Statement
Turnover72.4771.1270.49
Operating Profit3.503.542.78
Net Profit-0.22-1.340.23
Reported EPS-0.40-2.200.40
Balance Sheet
Current Assets38.7530.9029.79
Non Current Assets104.8097.3494.64
Total Assets143.55128.24124.44
Current Liabilities19.7617.9319.38
Total Liabilities56.9546.3542.84
Total Equity86.5981.8981.59
Cash Flow
Operating Cash Flow9.5913.0111.31
Net Change in Cash0.40-1.72-0.65

Regulatory News

DateAuthor Headline
28/12/2018David Brenchley 5 Worst-Performing FTSE 100 Stocks in 2018
The FTSE 100 has suffered from numerous troubles in 2018 - hit by trade and political uncertainty. We round up the worst performers
27/12/2018David Brenchley 5 Best FTSE 100 Stocks of 2018
It has been a troubled year for UK stocks, with fewer than a third of the FTSE 100 constituents in the green. We round up the best performers
24/12/2018Holly Black Ethical Funds for a Greener Christmas
With investors increasingly keen to make a positive impact with their money, what funds do experts recommend?
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
13/07/2021SaleMr. Arthur Francis Nicholas Wills Marquess of Downshire300.0033,409100,227.00
08/07/2021PurchaseMs. Jennifer Ann Julia Winter285.007,00019,950.00
08/07/2021PurchaseMr. Jan Marcel Matthieu Maria Boone285.0087,719249,999.00
08/07/2021PurchaseMr. Marc Armand Alice Andre Liliane Coucke285.00701,7612,000,019.00

Company Profile

Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.

Sector

Medical Care Facilities

Index

FTSE AIM All-Share

Next Event 30/03/2022

Final Results
Ratios
Comp
More ...
PER (E)3,420.00
Div Yld (E)1.17
PEG (E)0.00
ROCE0.68
Op Mrgn0.04
EPS Grwth-0.25
Dividends
PreviousLatest
More ...
Record Date04/06/2122/10/21
Ex-Div03/06/2121/10/21
Paid02/07/2119/11/21
Amnt2.002.00
Directors
More ...
Executive Director, Chief Executive OfficerMs. Jennifer Ann Julia Winter
Non-Executive Director, Senior Independent DirectorMr. Edwin Thomas William Torr
Non-Executive DirectorMr. Arthur Francis Nicholas Wills Marquess of Downshire
Non-Executive Director, ChairmanMr. Jan Marcel Matthieu Maria Boone
Non-Executive DirectorMr. Marc Armand Alice Andre Liliane Coucke
Executive Director, Chief Financial Officer and Company SecretaryMr. Christopher Brewster
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.